Liquidia Corporation Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
MORRISVILLE, N.C., Aug. 22, 2022 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) today announced the grant ...
Read moreMORRISVILLE, N.C., Aug. 22, 2022 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) today announced the grant ...
Read moreBRISBANE, Calif., Aug. 17, 2022 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a clinical-stage biopharmaceutical company ...
Read moreViridian Therapeutics, IncWALTHAM, Mass., Aug. 05, 2022 (GLOBE NEWSWIRE) -- Viridian Therapeutics, Inc. (Nasdaq: VRDN) (the ...
Read morePARSIPPANY, N.J.--(BUSINESS WIRE)--IVERIC bio, Inc. (NASDAQ: ISEE) today reported that on August 1, 2022, the Company ...
Read moreREDWOOD CITY, Calif. & BOSTON--(BUSINESS WIRE)--Adicet Bio, Inc. (Nasdaq: ACET), a clinical-stage biotechnology company discovering and ...
Read moreWASHINGTON, July 8 (Reuters) - Cheniere Energy Inc (LNG.A) has asked the Biden administration to exempt ...
Read moreWESTLAKE VILLAGE, Calif., July 05, 2022 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a late-stage ...
Read moreGiven the tumultuous start to the year for the S&P 500, it's no wonder retirees and ...
Read morePeople want to save more and spend less. Getting into the habit of spending less can ...
Read moreFLORHAM PARK, N.J., Dec. 23, 2021 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage ...
Read more© 2022 TheDailyStock.News